Ageing - Pipeline Review, H1 2016

  • ID: 3734786
  • Report
  • 57 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Bioo Therapeutics
  • Mapreg S.A.S.
  • Theravasc, Inc.
  • MORE
Ageing - Pipeline Review, H1 2016

Summary

‘Ageing - Pipeline Review, H1 2016’, provides an overview of the Ageing pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ageing, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ageing and features dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Ageing
- The report reviews pipeline therapeutics for Ageing by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Ageing therapeutics and enlists all their major and minor projects
- The report assesses Ageing therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Ageing

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Ageing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ageing pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bioo Therapeutics
  • Mapreg S.A.S.
  • Theravasc, Inc.
  • MORE
List of Tables

List of Figures

Introduction

Report Coverage

Ageing Overview

Therapeutics Development

Pipeline Products for Ageing - Overview

Pipeline Products for Ageing - Comparative Analysis

Ageing - Therapeutics under Development by Companies

Ageing - Therapeutics under Investigation by Universities/Institutes

Ageing - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Ageing - Products under Development by Companies

Ageing - Products under Investigation by Universities/Institutes

Ageing - Companies Involved in Therapeutics Development

Araim Pharmaceuticals, Inc.

Bioo Therapeutics

Mapreg S.A.S.

RepliCel Life Sciences, Inc.

RXi Pharmaceuticals Corporation

Theravasc, Inc.

Ageing - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

BIOO-4 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

BIOO-7 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

cibinetide - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Drugs for Ageing - Drug Profile

Product Description

Mechanism of Action

R&D Progress

MAP-46 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

MG-29 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

MMP-26051 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

MMP-26052 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

RCS-01 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

sirolimus - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Activate Telomerase for ALS, GVHD, Ageing and Leukemia - Drug Profile

Product Description

Mechanism of Action

R&D Progress

sodium nitrite SR - Drug Profile

Product Description

Mechanism of Action

R&D Progress

TM-5441 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Ageing - Recent Pipeline Updates

Ageing - Dormant Projects

Ageing - Product Development Milestones

Featured News & Press Releases

Dec 17, 2015: RepliCel Announces Completion of First Injections in Clinical Trial of RCS-01 for Skin Aging and UV-Damaged Skin

Sep 15, 2015: RepliCel Life Sciences Announces Initiation of Clinical Site and Participant Recruitment for European Skin Aging Study

Jul 21, 2015: RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial

Feb 23, 2015: RepliCel Submits Clinical Trial Application for its Dermatological Clinical Trial

Oct 09, 2014: RepliCel to Present Commercial and Clinical Update on RCS-01 at BioJapan 2014 World Business Forum

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Ageing, H1 2016

Number of Products under Development for Ageing - Comparative Analysis, H1 2016

Number of Products under Development by Companies, H1 2016

Number of Products under Investigation by Universities/Institutes, H1 2016

Comparative Analysis by Clinical Stage Development, H1 2016

Comparative Analysis by Early Stage Development, H1 2016

Products under Development by Companies, H1 2016

Products under Investigation by Universities/Institutes, H1 2016

Ageing - Pipeline by Araim Pharmaceuticals, Inc., H1 2016

Ageing - Pipeline by Bioo Therapeutics, H1 2016

Ageing - Pipeline by Mapreg S.A.S., H1 2016

Ageing - Pipeline by RepliCel Life Sciences, Inc., H1 2016

Ageing - Pipeline by RXi Pharmaceuticals Corporation, H1 2016

Ageing - Pipeline by Theravasc, Inc., H1 2016

Assessment by Monotherapy Products, H1 2016

Number of Products by Stage and Target, H1 2016

Number of Products by Stage and Mechanism of Action, H1 2016

Number of Products by Stage and Route of Administration, H1 2016

Number of Products by Stage and Molecule Type, H1 2016

Ageing Therapeutics - Recent Pipeline Updates, H1 2016

Ageing - Dormant Projects, H1 2016

List of Figures

Number of Products under Development for Ageing, H1 2016

Number of Products under Development for Ageing - Comparative Analysis, H1 2016

Number of Products under Development by Companies, H1 2016

Number of Products under Investigation by Universities/Institutes, H1 2016

Comparative Analysis by Early Stage Products, H1 2016

Assessment by Monotherapy Products, H1 2016

Number of Products by Targets, H1 2016

Number of Products by Stage and Targets, H1 2016

Number of Products by Mechanism of Actions, H1 2016

Number of Products by Stage and Mechanism of Actions, H1 2016

Number of Products by Routes of Administration, H1 2016

Number of Products by Stage and Routes of Administration, H1 2016

Number of Products by Molecule Types, H1 2016

Number of Products by Stage and Molecule Types, H1 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Araim Pharmaceuticals, Inc.
Bioo Therapeutics
Mapreg S.A.S.
RepliCel Life Sciences, Inc.
RXi Pharmaceuticals Corporation
Theravasc, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll